Immunostimulatory monoclonal antibodies for cancer therapy
Ignacio Melero(Universidad de Navarra), Lieping Chen(Fujian Medical University)
Cited by 628
Related Papers
Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future
|Journal of Clinical Investigation|2015|1.4k
Cytokines in clinical cancer immunotherapy
|British Journal of Cancer|2018|1.2k
CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity
|Immunity|2020|749
Intratumoural administration and tumour tissue targeting of cancer immunotherapies
|Nature Reviews Clinical Oncology|2021|469
OX40 Agonist BMS-986178 Alone or in Combination With Nivolumab and/or Ipilimumab in Patients With Advanced Solid Tumors
|Clinical Cancer Research|2020|109